77% of patients (150 mg Q4W) treated with barzolvolimab who had angioedema at baseline were angioedema free at Week 52 Data further support barzolvolimab clinical benefit to patients with CSU “The ...

In both CSU and RA, disease control scores positively correlated with QoL scores, meaning better disease control was associated with better QoL. Despite this correlation, 5.9% of CSU patients and 28% ...

Chronic urticaria (CU) is a dermatological condition characterized by recurrent wheals (hives), angioedema (deep tissue swelling), or both, persisting for over 6 weeks. 1 Unlike acute urticaria, which ...

An estimated 20% of people in the U.S. have hives at least once during their lifetime. The sudden appearance of these extremely itchy, red or skin-colored bumps and welts, with or without swelling ...

A prominent feature of CSU is its association with angioedema, observed in approximately 40% to 50% of patients with CSU; around 10% of patients primarily experience angioedema as the main symptom.

Chronic urticaria is defined as wheals (hives), angioedema (swelling), or both that have been continuously or intermittently present for at least 6 weeks, 1,2 in contrast to acute urticaria, which is ...

Hereditary angioedema (HAE) is a rare genetic condition that causes swelling under the skin and lining of your gut and lungs. “Angio” means it affects your blood vessels. “Edema” means swelling. So ...

With chronic urticaria on the rise, the CURE study calls for greater awareness on guideline-recommended classification, diagnostic workup, and treatment.

Optimal care for female and pediatric patients with hereditary angioedema (HAE) requires consideration of several population-specific issues. For women, these include menstruation, contraception, ...